NAPLEX (North American Pharmacist Licensure Examination) Practice Exam

Question: 1 / 1820

What does the administration of Parathyroid hormone 1-34 recommend for?

Very low-risk patients

Patients with moderate risk of fractures

Very high-risk patients

The administration of Parathyroid hormone 1-34 is recommended for very high-risk patients. This hormone is used in the treatment of osteoporosis in postmenopausal women who are at high risk of fractures and have failed other osteoporosis therapies. It is typically not recommended for very low-risk patients, patients with moderate risk of fractures, or all patients as preventive treatment.

Get further explanation with Examzify DeepDiveBeta

All patients as preventive treatment

Next Question

Report this question

Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy